Administrative, Leadership Development and Advocacy Core

$366,097P50FY2025CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications & trials

Paper 39602541 Paper 39464080 Paper 39198404 Paper 39069167 Paper 38959335 Paper 38906115 Paper 38700835 Paper 38536082 Paper 38441967 Paper 38367868 Paper 38255301 Paper 38191557 Paper 38191242 Paper 38030378 Paper 37831104 Paper 37721526 Paper 37347559 Paper 37292972 Paper 37169162 Paper 37125636 Paper 37014264 Paper 36780304 Paper 36755058 Paper 36476474 Paper 36243543 Paper 35931888 Paper 35476451 Paper 35468964 Paper 35405009 Paper 35294249 Paper 35110415 Paper 35094010 Paper 34993496 Paper 34598946 Paper 34503355 Paper 34349243 Paper 34081322 Paper 34035460 Paper 33861991 Paper 33827814 Paper 33795875 Paper 33677108 Paper 33637566 Paper 33420417 Paper 33194772 Paper 33087323 Paper 32855270 Paper 32814769 Paper 32795228 Paper 32540218 Paper 32483223 Paper 32366527 Paper 32241291 Paper 32216312 Paper 31969336 Paper 31905248 Paper 31679823 Paper 31669135 Paper 31591454 Paper 31572678 Paper 31554654 Paper 31546818 Paper 31501807 Paper 31446896 Paper 31324884 Paper 31151679 Paper 31139703 Paper 30952632 Paper 30950412 Paper 30926382 Paper 30697579 Paper 30655600 Paper 30642609 Paper 30612936 Paper 30517868 Paper 30511964 Paper 30503851 Paper 30482772 Paper 30479348 Paper 30309687 Paper 30297360 Paper 30236853 Paper 30108099 Paper 30059289 Paper 29951640 Paper 29923209 Paper 29852180 Paper 29849114 Paper 29765545 Paper 29760221 Paper 29716922 Paper 29686284 Paper 29624463 Paper 29590007 Paper 29578515 Paper 29559559 Paper 29556048 Paper 29525346 Paper 29518696 Paper 29478736

Abstract

CORE A: ABSTRACT The SPORE in Prostate Cancer brings together a highly motivated multidisciplinary team of investigators from Northwestern University and the University of Chicago, with contributions from NorthShore University HealthSystem (UC affiliate). The team includes laboratory scientists, urologists, medical oncologists, pathologists, biostatisticians and bioinformaticians, all of whom are dedicated to conducting state-of-the-art translational research to develop and test interventions that improve the outcome of patients diagnosed with prostate cancer.

View original record on NIH RePORTER →